Medicofarma Biotech S.A.
Medicofarma Biotech S.A. operates in Biotechnology.
Medicofarma Biotech S.A. (MDB) - Net Assets
Latest net assets as of : zł- PLN
Based on the latest financial reports, Medicofarma Biotech S.A. (MDB) has net assets worth zł- PLN as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł-) and total liabilities (zł-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Medicofarma Biotech S.A. - Net Assets Trend (None–None)
This chart illustrates how Medicofarma Biotech S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Medicofarma Biotech S.A. (None–None)
The table below shows the annual net assets of Medicofarma Biotech S.A. from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Medicofarma Biotech S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Medicofarma Biotech S.A. Competitors by Market Cap
The table below lists competitors of Medicofarma Biotech S.A. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LODESTAR MIN
BE:3EJ
|
$823.79 |
|
CRESTA MARAKANELO LIMITED
XBOT:CRE-EQO
|
$824.78 |
|
Vietnam Enterprise Investments Limited
LSE:VEIL
|
$826.00 |
|
Aberdeen New India Investment Trust PLC
LSE:ANII
|
$826.37 |
|
Friendable Inc
PINK:FDBL
|
$822.66 |
|
Grupa Modne Zakupy S.A.
WAR:GMZ
|
$821.10 |
|
Malvern International
LSE:MLVN
|
$820.81 |
|
Quality Hospitality Leasehold Property Fund
BK:QHOP
|
$817.98 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Medicofarma Biotech S.A.'s equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Medicofarma Biotech S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Medicofarma Biotech S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Medicofarma Biotech S.A.'s net assets metrics with peer companies in the Biotechnology & Medical Research industry.
Industry Context
- Industry: Biotechnology & Medical Research
- Average net assets among peers: $5,333,873
- Average return on equity (ROE) among peers: -2.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Medicofarma Biotech S.A. (MDB) | zł- | N/A | N/A | $823.22 |
| Readgene (RDG) | $3.24 Million | -2.36% | 3.67x | $12.88K |
| SCS (SCS) | $7.43 Million | -2.08% | 0.83x | $909.17 |